About Us

arrow-icon
Back to About Us
member-photo-1

James L. Sherley, M.D., Ph.D.

Associate Scholar

James L. Sherley graduated from Harvard College in 1980 with a B.A. degree in biology; and he completed joint M.D. and Ph.D. degrees at the Johns Hopkins University School of Medicine in 1988. After post-doctoral studies in cancer cell molecular biology at Princeton University, he joined the Fox Chase Cancer Center as a principal investigator in 1991. In 1998, he joined the faculty of the future Department of Biological Engineering at Massachusetts Institute of Technology, where he undertook research and teaching in the areas of cancer cell molecular biology, tissue stem cell bioengineering, toxicology, and environmental health science until moving to Boston Biomedical Research Institute (BBRI) in 2007. As a Senior Member of BBRI’s research programs in Regenerative Biology and Cancer Biology, Dr. Sherley established an academic center for developing adult stem cell-based technologies for advancing cellular medicine. After leaving BBRI, in October 2013 he founded Asymmetrex, LLC, which he now directs as President and CEO. Asymmetrex has the mission of advancing technologies for stem cell medicine. The company recently developed the first method of determining the dosage of therapeutic adult stem cells. Dr. Sherley’s awards include 1993 Pew Biomedical Research Scholar, 2003 Ellison Medical Foundation Senior Scholar in Aging Research, and 2006 NIH Director’s Pioneer Award. He is also “PGP-10” in the Personal Genome Project at Harvard Medical School.

Latest Research & News

  • Questions and Answers on Late-Term Abortion | May 16, 2022

    First published: February 2019 Last updated: May 16, 2022   To view this fact sheet as a PDF, see: Fact Sheet: Questions and Answers on Late-Term Abortion   What is a Late-Term Abortion?   “Late-term” abortion is an imprecise term, but under any “formal” definition offered or as accepted by the public at large late-term […]

  • Handbook of Nascent Human Beings: A Visual Aid for Understanding the Science and Experimentation | February 25, 2022

    Updated April 28, 2022   This is Issue 8 in CLI’s On Science series. To view this report as a PDF, see: Handbook of Nascent Human Beings: A Visual Aid for Understanding the Science and Experimentation   Introduction to the Handbook   The purpose of this handbook is to provide a useful reference guide to […]

  • Closing the Slippery Slope from a 14-Day Rule to an N-Day Rule | November 12, 2021

    This is issue 6 in CLI’s On Science series. To view this report as a PDF, see: Closing the Slippery Slope from a 14-Day Rule to an N-day Rule     Introduction   A common point of contention in bioethics discourse is whether a metaphorical “slippery slope” exists for human experimentation that is allowed despite […]

  • A Policy and Funding Evaluation Of Human Fetal Tissue Research | September 11, 2020

    This is Issue 2 in CLI’s On Science. To view this report as a PDF, see: A Policy and Funding Evaluation Of Human Fetal Tissue Research   Background The body parts of preborn babies that die through the act of elective abortion are harvested and sold to desiring scientists for experimentation.  These acts are heinous, […]

  • An Ethics Assessment of COVID-19 Vaccine Programs | May 6, 2020

    Latest COVID-19 Vaccine Chart   This is Issue 46 in CLI’s On Point Series. To view this report as a PDF, see: On Point 46: An Ethics Assessment of COVID-19 Vaccine Programs    This page outlines the ethical considerations involved solely in vaccine production, based on information present at the time of publication. Subsequently, publication […]

  • Testimony of Dr. James Sherley, M.D., Ph.D. in Support of Missouri Bills regarding Humane Treatment of Aborted Fetal Remains | February 24, 2016

    On February 23, the Missouri House Children and Families Committee heard five bills on issues stemming from the Center for Medical Progress’s undercover video exposé of Planned Parenthood, including: the sale and final disposition of aborted fetal remains, post-abortion tissue reporting requirements, and employee protections for whistleblowers.

    Among those who testified in support of the bills was Dr. James Sherley, M.D., Ph.D., a physician scientist with expertise in biomedical research, cancer biology, and adult stem cell engineering. Dr. Sherley is founder and director of Asymmetrex, LLC, which develops new technologies for ethical adult stem cell medicine and drug discovery.